Self · Ultragenyx Pharmaceutical Inc. · Ultragenyx Pharmaceutical Inc. - Common Stock
Purchase
Disclosed range starting at $1K
Disclosed 35 days after execution (STOCK Act deadline: 45)
1 prior trade recorded in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Read directly from the primary public document; every field below is as reported by the filer.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
= $8,001
Gilbert Ray Cisneros, Jr. reported a purchase of Ultragenyx Pharmaceutical Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.
